Enanta Pharmaceuticals Inc (ENTA)
12.49
+0.49
(+4.08%)
USD |
NASDAQ |
May 31, 16:00
12.43
-0.06
(-0.48%)
After-Hours: 20:00
Enanta Pharmaceuticals Cash and Short Term Investments (Quarterly): 300.31M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 300.31M |
| December 31, 2023 | 337.15M |
| September 30, 2023 | 369.91M |
| June 30, 2023 | 386.58M |
| March 31, 2023 | 210.08M |
| December 31, 2022 | 214.47M |
| September 30, 2022 | 249.23M |
| June 30, 2022 | 253.29M |
| March 31, 2022 | 280.33M |
| December 31, 2021 | 259.05M |
| September 30, 2021 | 244.00M |
| June 30, 2021 | 256.82M |
| March 31, 2021 | 375.95M |
| December 31, 2020 | 386.20M |
| September 30, 2020 | 386.65M |
| June 30, 2020 | 370.00M |
| March 31, 2020 | 355.26M |
| December 31, 2019 | 373.78M |
| September 30, 2019 | 335.24M |
| June 30, 2019 | 389.25M |
| March 31, 2019 | 370.16M |
| December 31, 2018 | 345.79M |
| September 30, 2018 | 308.73M |
| June 30, 2018 | 273.23M |
| March 31, 2018 | 256.72M |
| Date | Value |
|---|---|
| December 31, 2017 | 220.44M |
| September 30, 2017 | 223.67M |
| June 30, 2017 | 192.02M |
| March 31, 2017 | 175.57M |
| December 31, 2016 | 209.36M |
| September 30, 2016 | 210.08M |
| June 30, 2016 | 218.46M |
| March 31, 2016 | 220.42M |
| December 31, 2015 | 180.02M |
| September 30, 2015 | 145.20M |
| June 30, 2015 | 154.29M |
| March 31, 2015 | 165.47M |
| December 31, 2014 | 104.02M |
| September 30, 2014 | 90.76M |
| June 30, 2014 | 95.89M |
| March 31, 2014 | 94.77M |
| December 31, 2013 | 91.90M |
| September 30, 2013 | 101.48M |
| June 30, 2013 | 94.55M |
| March 31, 2013 | 109.11M |
| December 31, 2012 | 45.48M |
| September 30, 2012 | 43.76M |
| June 30, 2012 | 46.76M |
| September 30, 2011 | 23.33M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
210.08M
Minimum
Mar 2023
389.25M
Maximum
Jun 2019
316.68M
Average
336.19M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Madrigal Pharmaceuticals Inc | 1.059B |
| Galectin Therapeutics Inc | 23.56M |
| Viking Therapeutics Inc | 962.98M |
| Akero Therapeutics Inc | 903.66M |
| 89bio Inc | 562.29M |